Atlas Trials

Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease

Clinical trial NCT00933608 · COMPLETED

Trial details

NCT number
NCT00933608
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2009-07-01
Primary completion
2011-09-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.